Dashboard
Manage Tickers

MREO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-mereo-biopharma-group-raises-price-target-to-8
JP Morgan Maintains Overweight on Mereo Bi...
08/25/2025 14:14:55

JP Morgan analyst Priyanka Grover maintains Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and raises the price targe...

mereo-biopharma-and-shibio-announce-exclusive-licensing-agreement-for-vantictumab-in-autosomal-dominant-osteopetrosis-type-2-shibio-has-exclusive-license-to-develop-and-commercialize-vantictumab-globally-excluding-europe-where-mereo-retains-commercial-rights
Mereo BioPharma And āshibio Announce Exclu...
08/19/2025 12:36:30

mereo-biopharma-group-q2-eps-002-misses-001-estimate-sales-500000k
Mereo BioPharma Group Q2 EPS $(0.02) Misse...
08/12/2025 11:38:36

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate ...

ultragenyx-represents-intriguing-buying-opportunity-despite-recent-setbacks
Ultragenyx Represents 'Intriguing Buying O...
07/28/2025 17:16:04

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 17:05:47

crude-oil-down-over-2-delta-air-lines-posts-upbeat-earnings
Crude Oil Down Over 2%; Delta Air Lines Po...
07/10/2025 17:04:43

us-stocks-mixed-initial-jobless-claims-fall
US Stocks Mixed; Initial Jobless Claims Fall
07/10/2025 14:46:41

ultragenyx-mereo-shares-dive-as-brittle-bone-disease-drug-misses-early-win
Ultragenyx, Mereo Shares Dive As Brittle B...
07/10/2025 14:06:42

Ultragenyx shares fall after Phase 3 study misses interim target, but analysts remain positive ahead of final OI data expected ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 12:09:22

methode-electronics-ultragenyx-pharmaceutical-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Methode Electronics, Ultragenyx Pharmaceut...
07/10/2025 12:00:22

needham-maintains-buy-on-mereo-biopharma-group-lowers-price-target-to-5
Needham Maintains Buy on Mereo BioPharma G...
07/10/2025 10:19:13

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and lowers the price target from $7 to $5.

why-wk-kellogg-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket
Why WK Kellogg Shares Are Trading Higher B...
07/10/2025 09:47:28

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 21:06:40

Core News & Articles
Ultragenyx And Mereo BioPharma To Complete...
07/09/2025 20:08:08

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO), today announced that the randomized, ...

rio-tinto-bumble-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Rio Tinto, Bumble And Other Big Stocks Mov...
06/03/2025 12:31:22

why-credo-technology-group-shares-are-trading-higher-by-over-14-here-are-20-stocks-moving-premarket
Why Credo Technology Group Shares Are Trad...
06/03/2025 10:30:29

needham-reiterates-buy-on-mereo-biopharma-group-maintains-7-price-target
Needham Reiterates Buy on Mereo BioPharma ...
05/13/2025 14:01:01

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $7 price target.

correction-mereo-biopharma-q1-gaap-eps-002-misses-001-estimate-cash-and-equivalents-of-625m
CORRECTION: Mereo BioPharma Q1 GAAP EPS $(...
05/13/2025 12:41:32

needham-reiterates-buy-on-mereo-biopharma-group-maintains-7-price-target
Needham Reiterates Buy on Mereo BioPharma ...
04/09/2025 12:14:56

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $7 price target.

jp-morgan-initiates-coverage-on-mereo-biopharma-group-with-overweight-rating-announces-price-target-of-7
JP Morgan Initiates Coverage On Mereo BioP...
03/27/2025 12:15:08

JP Morgan analyst Priyanka Grover initiates coverage on Mereo BioPharma Group (NASDAQ:MREO) with a Overweight rating and ann...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION